Albumin-based Half-life Extension

Making Products Better Together with Novozymes Biopharma

At Novozymes, we combine the specific application knowledge of our customers with our unique...

February 03, 2023 | 29:53

Nikkei SDGs Festival December 2022

Watch Ester (EBG) Peter Taksoe-Jensen (Danish Ambassador to Japan)'s dialogue on how bio-based...

October 07, 2022 | 01:37

Let's accelerate towards a climate-neutral society

Time to rethink the big picture Did you know that we need to reduce our global greenhouse gas...

March 16, 2022 | 01:09

See how efficiently Novozymes enzymes capture carbon...

As you can see in this Novozymes lab demonstration, carbonic anhydrase captures millions of...

Albumin-based Half-life Extension

The albumin based technology can be used for the reduction of drug dosing frequency and the increase of patient compliance. Genetic fusion – Albufuse® Flex is suitable for non-synthetic peptides whereas chemical conjugation – Recombumin® Flex is most appropriate for non-natural or synthesized peptides.